According to MobiHealthNews, Nurx has raised $36 million in a Series B funding round led by Kleiner Perkins Caufield & Byers, with participation from Union Square Ventures, Y Combinator, and Lowercase Capital.

Nurx is a telehealth company committed to being a global industry leader in a market projected to surpass $36 billion by 2020. Founded by a Hans Gangeskar and Dr. Edvard Engesaeth, MD, Nurx makes birth control and Truvada for PrEP more accessible through telemedicine. Users are able to receive prescriptions with online doctors and have their medication delivered right to their door through the app.